Open Access

Erratum to: Suppression of apoptosis inhibitor c-FLIP selectively eliminates breast cancer stem cell activity in response to the anti-cancer agent, TRAIL

  • Luke Piggott1, 2,
  • Nader Omidvar1,
  • Salvador Martí Pérez2,
  • Rhiannon French1,
  • Matthias Eberl2 and
  • Richard WE Clarkson1Email author
Contributed equally
Breast Cancer Research201517:96

https://doi.org/10.1186/s13058-015-0597-9

Received: 28 May 2014

Accepted: 21 July 2014

Published: 16 July 2015

The original article was published in Breast Cancer Research 2011 13:R88

Correction

While compiling the article [1] one of the authors was inadvertently omitted from the author list. This author, Rhiannon French, has been included in the corrected author list above.

Notes

Declarations

Acknowledgements

We thank Christien Gabriel and Dawn Roberts for technical support. This study was funded by a Tenovus PhD scholarship (LP), seed-corn funding from the Breast Cancer Campaign (RC) and additional part-funding from CR-UK (ME) and BBSRC (NO). RC and ME are RC-UK Research Fellows.

Authors’ Affiliations

(1)
Life Sciences Building, Cardiff University School of Biosciences
(2)
Department of Infection, Immunity and Biochemistry, Cardiff University School of Medicine

Reference

  1. Piggott L, Omidvar N, Martí Pérez S, Eberl M, Clarkson RWE. Suppression of apoptosis inhibitor c-FLIP selectively eliminates breast cancer stem cell activity in response to the anti-cancer agent, TRAIL. Breast Canc Res. 2011;13:R88.View ArticleGoogle Scholar

Copyright

© Piggott et al. 2015

This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Advertisement